The Promise and Challenges of Regenerative Medicine, Cancer Detection, and Advanced Therapies

DENPASAR, NusaBali.com - Regenerative medicine is a method of treatment by replacing tissues or organs that have been damaged by age, disease, trauma, or congenital problems, as opposed to current clinical strategies that focus primarily on treating symptoms.

The tools used to realize this outcome are tissue engineering, cellular therapy, and artificial medical devices and organs.

Regenerative Medicine is expected to grow significantly by USD38 billion by 2030. This refers to ‘Regenerative Medicine’ as stem cells, exosomes, and growth hormone therapy. The growth rate of exosomes is 32.75% per year. The peptide industry is larger in volume, estimated to grow to USD80 billion by 2030.

This was stated by health expert Dr Widya Murni MARS, a practitioner from the Jakarta Aging Center and a doctor who is an expert in handling health related to anti-aging medicine in a press release on Thursday (23/11/2023).

Beware of gas therapy such as oxygen (hyperbaric oxygen), hydrogen therapy and carbon dioxide therapy. The sales volume of hyperbaric oxygen increases 10-fold every 5 years due to its effectiveness and popularity. 

Modernization and industrialization led to an epidemic explosion of chronic and degenerative diseases namely Cardiovascular, metabolic diseases, cellular energy system disorders and cancer. The very short list here already covers more than 2/3 volume of the medical industry.

The Global Oncology Market is valued at USD 305.07 billion by 2022, poised to grow at a noteworthy CAGR of 8.8% from 2023 to 2032. The Global Oncology Market valuation will reach USD 556.35 billion by 2030.

Cancer is not incurable, but current diagnostic methodologies detect cancer at a very late stage. A solid tumor one centimeter in diameter, the person has had cancer for 6 years. Three centimeters in diameter, it's been 9 years. We need a better screening system and I will show how new technology can do this. 

Furthermore, cancer laboratories around the world show that cancer cells enter the bloodstream at a very early stage, as early as the first few months or the first few years. Now we need early cancer detection more than ever and this technology has arrived at your doorstep. This showcase is the best CTC system with 98% sensitivity and 100% accuracy or specificity.

On the other hand, there is increasing concern that regenerative medicine may activate the underlying cancer cells to grow faster and confirmed in animal models and valid observations in practice. 

In Taiwan, using the world's most sensitive CTC system, 3 out of 10 people who sought stem cell therapy treatment in the hope of better health were found to have cancer cells in their circulating blood. Practitioners' insistence on the right and better approach is gratifying based on the principle of ‘do no harm’. 

Contrary to the belief that most people have cancer in the circulating blood, it is not true that perfectly healthy people do not carry cancer cells in the circulating blood. When cancer cells are detected in the blood circulation, they should be treated as early-stage cancer and should not be started with regenerative medicine approaches. 

Regarding cancer treatment, an analysis from the US NIH, over 60 years, chemotherapy for cancer has only improved survival by one percent despite more than a trillion USD spent on research over the same period. 

Some call it an outdated system which means scrap it and replace it with a better system. I am not here to start this rhetoric but to point out what else we can do, i.e. immune restoration therapies such as Dendritic cell therapy, Natural Killer therapy, cytokine therapy, immuno (better than GcMAF 100 times) etc. These therapies are new advances in the field of medicine. These therapies are new advances in cancer treatment that show much better survival outcomes. 

Records show that for any cancer (solid tumors), when hyperthermia is added to the conventional standard of care, five-year survival jumps by 20-100%. The Lancet even stated in the conclusion of its study, every center offering treatment for cancer should provide hyperthermia services. In another paper, at the stage where there is nothing to offer, hyperthermia still has a role to help that should be considered.

Meanwhile, health expert and practitioner Dr Zawawi Abdullah pointed out that there are several Stem Cell methods offered, but only here is a more holistic examination of whether or not there are cancer cells in the patient's body and how many Natural Killer cells (natural immune system builders). 

So if it is proven that there are cancer cells, what is treated is not stem cells but Natural Killer Cells. Conversely, if it is proven that there are no cancer cells, but the Natural Killer Cell is low, then we can give Natural killer Cell first and then stem cell therapy.

Regenerative Medicine is the focus of the December 29, 2023 Health Expert Meeting in Cannabali, Kuta Selatan, Kabupaten Badung, Bali.